Lumida
/ATAI
⌘K
ATAI Life Sciences NV

ATAI Life Sciences NV

ATAI
$7.35USD+0.82%+0.06 today

MARKET CAP

2.7B

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$3
$7

AI Summary

Stalk
StalkMedium

ATAI maintains its Stage 2 uptrend, but the active Bullish Exhaustion inflection pattern and recent pullback from highs signal waning upside momentum. Under a Speculative strategy, bullish engagement should be deferred to pullbacks into the rising 9/20 EMA support area for better asymmetry.

  • $430.3M cash & equivalents funds operations through 2023
  • 11 clinical programs targeting mental health disorders
  • Q2 revenue $1.7M, down 142.8% YoY, highlighting weak top line
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income